MediciNova, Inc. Reports Third Quarter 2009 Results
11/13/2009 9:54:41 AM
More...
|
MediciNova, Inc. Announces Initiation of a Phase Ib Clinical Trial for MN-221 in Patients With Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease
11/4/2009 8:39:04 AM
More...
|
MediciNova, Inc. Appoints Mr. Hiroaki Shigeta to Its Board of Directors
9/16/2009 8:59:44 AM
More...
|
MediciNova, Inc. to Present At the Rodman & Renshaw Annual Global Investment Conference
9/4/2009 8:52:28 AM
More...
|
MediciNova, Inc. to Buy Avigen, Inc. (AVGN) for About $37 Million
8/21/2009 6:30:01 AM
More...
|
MediciNova, Inc. Reports Second Quarter 2009 Results
8/14/2009 8:43:53 AM
More...
|
MediciNova, Inc. Announces Proposed Final Protocol for Its Phase II Placebo-Controlled Clinical Trial Evaluating MN-221 in Patients With Severe, Acute Exacerbations of Asthma
7/14/2009 8:46:57 AM
More...
|
MediciNova, Inc. and Avigen, Inc. (AVGN) Confirm Understanding for Key Terms for a Business Combination
6/25/2009 9:41:39 AM
More...
|
MediciNova, Inc. Announces Plan to Modify Its Phase II Placebo-Controlled Clinical Trial Evaluating MN-221 in Patients With Severe, Acute Exacerbations of Asthma
5/29/2009 9:07:19 AM
More...
|
MediciNova, Inc. Reports First Quarter 2009 Results
5/15/2009 9:43:01 AM
More...
|
|